Phospholipases: An overview

Methods in Molecular Biology

Volumn 861, Issue , 2012, Pages 63-85

  Aloulou, Ahmed ^a   Ali, Yassine Ben ^a   Bezzine, Sofiane ^a   Gargouri, Youssef ^a   Gelb, Michael H ^b  

^a UNIVERSITY OF SFAX   (Tunisia)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Classification; Industrial application; Phospholipases; Physiological function

Indexed keywords

PHOSPHOLIPASE; PHOSPHOLIPID;

ANIMAL; BIOTECHNOLOGY; CHEMISTRY; CLASSIFICATION; ENZYME SPECIFICITY; ENZYMOLOGY; EUKARYOTIC CELL; HUMAN; METABOLISM; METHODOLOGY; PROKARYOTIC CELL; PROTEIN ENGINEERING; REVIEW;

ANIMALS; BIOTECHNOLOGY; EUKARYOTIC CELLS; HUMANS; PHOSPHOLIPASES; PHOSPHOLIPIDS; PROKARYOTIC CELLS; PROTEIN ENGINEERING; SUBSTRATE SPECIFICITY;

EID: 84859994928     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-600-5_4     Document Type: Review

References (170)

1. Exton JH (1997) New developments in phospholipase D. J Biol Chem 272:15579-15582 (Pubitemid 27265521)
2. Farn JL, Strugnell RA, Hoyne PA et al (2001) Molecular characterization of a secreted enzyme with phospholipase B activity from Moraxella bovis. J Bacteriol 183:6717-6720 (Pubitemid 33026768)
3. Singer WD, Brown HA, Sternweis PC (1997) Regulation of eukaryotic phosphatidylinositol- specifi c phospholipase C and phospholipase D. Annu Rev Biochem 66:475-509 (Pubitemid 27274665)
4. Bornscheuer UT, Kazlauskas RJ (2004) Catalytic promiscuity in biocatalysis: using old enzymes to form new bonds and follow new pathways. Angew Chem Int Ed Engl 43:6032-6040 (Pubitemid 39611872)
5. De Maria L, Vind J, Oxenboll KM et al (2007) Phospholipases and their industrial applications. Appl Microbiol Biotechnol 74:290-300 (Pubitemid 46204503)
6. Kazlauskas RJ (2005) Enhancing catalytic promiscuity for biocatalysis. Curr Opin Chem Biol 9:195-201 (Pubitemid 40462490)
7. Aoki J, Nagai Y, Hosono H et al (2002) Structure and function of phosphatidylserinespecifi c phospholipase A1. Biochim Biophys Acta 1582:26-32
8. Sato T, Aoki J, Nagai Y et al (1997) Serine phospholipid-specifi c phospholipase A that is secreted from activated platelets. A new member of the lipase family. J Biol Chem 272:2192-2198 (Pubitemid 27058499)
9. King TP, Kochoumian L, Joslyn A (1984) Wasp venom proteins: phospholipase A1 and B. Arch Biochem Biophys 230:1-12
10. Hiramatsu T, Sonoda H, Takanezawa Y et al (2003) Biochemical and molecular characterization of two phosphatidic acid-selective phospholipase A1s, mPA-PLA1alpha and mPA-PLA1beta. J Biol Chem 278:49438-49447
11. Carriere F, Withers-Martinez C, van Tilbeurgh H et al (1998) Structural basis for the substrate selectivity of pancreatic lipases and some related proteins. Biochim Biophys Acta 1376:417-432 (Pubitemid 28517890)
12. Simons JW, Gotz F, Egmond MR et al (1998) Biochemical properties of staphylococcal (phospho)lipases. Chem Phys Lipids 93:27-37 (Pubitemid 28383202)
13. Tiesinga JJ, van Pouderoyen G, Nardini M et al (2007) Structural basis of phospholipase activity of Staphylococcus hyicus lipase. J Mol Biol 371:447-456 (Pubitemid 47048272)
14. Heikinheimo P, Goldman A, Jeffries C et al (1999) Of barn owls and bankers: a lush variety of alpha/beta hydrolases. Structure 7:R141-R146 (Pubitemid 29277412)
15. Simons JW, Boots JW, Kats MP et al (1997) Dissecting the catalytic mechanism of staphylococcal lipases using carbamate substrates: chain length selectivity, interfacial activation, and cofactor dependence. Biochemistry 36:14539-14550 (Pubitemid 27509946)
16. Dekker N (2000) Outer-membrane phospholipase A: known structure, unknown biological function. Mol Microbiol 35:711-717 (Pubitemid 30107523)
17. Kingma RL, Fragiathaki M, Snijder HJ et al (2000) Unusual catalytic triad of Escherichia coli outer membrane phospholipase A. Biochemistry 39:10017-10022 (Pubitemid 30663022)
18. Snijder HJ, Dijkstra BW (2000) Bacterial phospholipase A: structure and function of an integral membrane phospholipase. Biochim Biophys Acta 1488:91-101
19. Schmiel DH, Wagar E, Karamanou L et al (1998) Phospholipase A of Yersinia enterocolitica contributes to pathogenesis in a mouse model. Infect Immun 66:3941-3951 (Pubitemid 28347859)
20. Murakami M, Taketomi Y, Miki Y et al (2011) Recent progress in phospholipase A(2) research: From cells to animals to humans. Prog Lipid Res 50:152-192
21. Schaloske RH, Dennis EA (2006) The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 1761:1246-1259 (Pubitemid 44755364)
22. Valentin E, Singer AG, Ghomashchi F et al (2000) Cloning and recombinant expression of human group IIF-secreted phospholipase A(2). Biochem Biophys Res Commun 279:223-228
23. Lee HY, Bahn SC, Shin JS et al (2005) Multiple forms of secretory phospholipase A2 in plants. Prog Lipid Res 44:52-67 (Pubitemid 40313219)
24. Ryu Y, Oh Y, Yoon J et al (2003) Molecular characterization of a gene encoding the Drosophila melanogaster phospholipase A2. Biochim Biophys Acta 1628:206-210 (Pubitemid 36976821)
25. McIntosh JM, Ghomashchi F, Gelb MH et al (1995) Conodipine-M, a novel phospholipase A2 isolated from the venom of the marine snail Conus magus. J Biol Chem 270:3518-3526
26. Kini RM (2003) Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon 42:827-840 (Pubitemid 38201486)
27. Valentin E, Lambeau G (2000) Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins. Biochim Biophys Acta 1488:59-70
28. Canaan S, Zadori Z, Ghomashchi F et al (2004) Interfacial enzymology of parvovirusphospholipases A2. J Biol Chem 279:14502-14508
29. Soragni E, Bolchi A, Balestrini R et al (2001) A nutrient-regulated, dual localization phospholipase A(2) in the symbiotic fungus Tuber borchii. EMBO J 20:5079-5090 (Pubitemid 32910904)
30. Sugiyama M, Ohtani K, Izuhara M et al (2002) A novel prokaryotic phospholipase A2. Characterization, gene cloning, and solution structure. J Biol Chem 277:20051-20058 (Pubitemid 34967529)
31. Matoba Y, Katsube Y, Sugiyama M (2002) The crystal structure of prokaryotic phospholipase A2. J Biol Chem 277:20059-20069
32. Valentin E, Ghomashchi F, Gelb MH et al (2000) Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme. J Biol Chem 275:7492-7496 (Pubitemid 30159644)
33. Singer AG, Ghomashchi F, Le Calvez C et al (2002) Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2. J Biol Chem 277:48535-48549 (Pubitemid 35470814)
34. Ni Z, Okeley NM, Smart BP et al (2006) Intracellular actions of group IIA secreted phospholipase A2 and group IVA cytosolic phospholipase A2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells. J Biol Chem 281:16245-16255
35. Mounier CM, Ghomashchi F, Lindsay MR et al (2004) Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha. J Biol Chem 279:25024-25038 (Pubitemid 38756751)
36. Bezzine S, Koduri RS, Valentin E et al (2000) Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes effi ciently release arachidonic acid from adherent mammalian cells. J Biol Chem 275:3179-3191 (Pubitemid 30083017)
37. Koduri RS, Gronroos JO, Laine VJ et al (2002) Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). J Biol Chem 277:5849-5857 (Pubitemid 34968364)
38. Webb NR (2005) Secretory phospholipase A2 enzymes in atherogenesis. Curr Opin Lipidol 16:341-344
39. Kudo I, Murakami M, Hara S et al (1993) Mammalian non-pancreatic phospholipases A2. Biochim Biophys Acta 1170:217-231
40. Akiba S, Hatazawa R, Ono K et al (2001) Secretory phospholipase A2 mediates cooperative prostaglandin generation by growth factor and cytokine independently of preceding cytosolic phospholipase A2 expression in rat gastric epithelial cells. J Biol Chem 276:21854-21862
41. Kim KP, Rafter JD, Bittova L et al (2001) Mechanism of human group V phospholipase A2 (PLA2)-induced leukotriene biosynthesis in human neutrophils. A potential role of heparan sulfate binding in PLA2 internalization and degradation. J Biol Chem 276:11126-11134 (Pubitemid 38089295)
42. Snitko Y, Yoon ET, Cho W (1997) High specifi city of human secretory class II phospholipase A2 for phosphatidic acid. Biochem J 321:737-741
43. Fourcade O, Simon MF, Viode C et al (1995) Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80:919-927
44. Atsumi G, Murakami M, Tajima M et al (1997) The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid. Biochim Biophys Acta 1349:43-54 (Pubitemid 27517522)
45. Nevalainen TJ, Graham GG, Scott KF (2008) Antibacterial actions of secreted phospholipases A2. Review. Biochim Biophys Acta 1781:1-9
46. Koprivnjak T, Peschel A, Gelb MH et al (2002) Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A2 against Staphylococcus aureus. J Biol Chem 277:47636-47644 (Pubitemid 36159285)
47. Chen J, Shao C, Lazar V et al (1997) Localization of group IIc low molecular weight phospholipase A2 mRNA to meiotic cells in the mouse. J Cell Biochem 64:369-375 (Pubitemid 27098622)
48. Tischfi eld JA, Xia YR, Shih DM et al (1996) Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human. Genomics 32:328-333 (Pubitemid 26094335)
49. Valentin E, Koduri RS, Scimeca JC et al (1999) Cloning and recombinant expression of a novel mouse-secreted phospholipase A2. J Biol Chem 274:19152-19160
50. Ishizaki J, Suzuki N, Higashino K et al (1999) Cloning and characterization of novel mouse and human secretory phospholipase A(2)s. J Biol Chem 274:24973-24979
51. Chen J, Engle SJ, Seilhamer JJ et al (1994) Cloning and recombinant expression of anovel human low molecular weight Ca(2+)- dependent phospholipase A2. J Biol Chem 269:2365-2368
52. Murakami M, Koduri RS, Enomoto A et al (2001) Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J Biol Chem 276:10083-10096
53. Kim YM, Lee YM, Kim HS et al (2002) TNFrelated activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem 277:6799-6805 (Pubitemid 34953061)
54. Balboa MA, Shirai Y, Gaietta G et al (2003) Localization of group V phospholipase A2 in caveolin-enriched granules in activated P388D1 macrophage-like cells. J Biol Chem 278:48059-48065 (Pubitemid 37523256)
55. Wijewickrama GT, Kim JH, Kim YJ et al (2006) Systematic evaluation of transcellular activities of secretory phospholipases A2. High activity of group V phospholipases A2 to induce eicosanoid biosynthesis in neighboring infl ammatory cells. J Biol Chem 281:10935-10944 (Pubitemid 43862167)
56. Munoz NM, Meliton AY, Lambertino A et al (2006) Transcellular secretion of group V phospholipase A2 from epithelium induces beta 2-integrin-mediated adhesion and synthesis of leukotriene C4 in eosinophils. J Immunol 177:574-582 (Pubitemid 43939171)
57. Ohtsuki M, Taketomi Y, Arata S et al (2006) Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. J Biol Chem 281:36420-36433 (Pubitemid 46041376)
58. Wooton-Kee CR, Boyanovsky BB, Nasser MS et al (2004) Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation. Arterioscler Thromb Vasc Biol 24:762-767 (Pubitemid 38451617)
59. Ishimoto Y, Yamada K, Yamamoto S et al (2003) Group V and X secretory phospholipase A(2)s-induced modifi cation of high-density lipoprotein linked to the reduction of its antiatherogenic functions. Biochim Biophys Acta 1642:129-138 (Pubitemid 37315656)
60. Gesquiere L, Cho W, Subbaiah PV (2002) Role of group IIa and group V secretory phospholipases A(2) in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin. Biochemistry 41: 4911-4920 (Pubitemid 34298658)
61. Mitsuishi M, Masuda S, Kudo I et al (2007) Human group III phospholipase A2 suppresses adenovirus infection into host cells. Evidence that group III, V and X phospholipase A2s act on distinct cellular phospholipid molecular species. Biochim Biophys Acta 1771:1389-1396 (Pubitemid 350217096)
62. Boilard E, Lai Y, Larabee K et al (2010) A novel anti-infl ammatory role for secretory phospholipase A2 in immune complex-mediated arthritis. EMBO Mol Med 2:172-187
63. Balestrieri B, Hsu VW, Gilbert H et al (2006) Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J Biol Chem 281:6691-6698 (Pubitemid 43847604)
64. Bradley JD, Dmitrienko AA, Kivitz AJ et al (2005) A randomized, double-blinded, placebo- controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. J Rheumatol 32:417-423 (Pubitemid 40381410)
65. Rosengren B, Peilot H, Umaerus M et al (2006) Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet. Arterioscler Thromb Vasc Biol 26:1579-1585 (Pubitemid 44288986)
66. Boyanovsky BB, van der Westhuyzen DR, Webb NR (2005) Group V secretory phospholipase A2-modifi ed low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans. J Biol Chem 280:32746-32752 (Pubitemid 41368320)
67. Bostrom MA, Boyanovsky BB, Jordan CT et al (2007) Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice. Arterioscler Thromb Vasc Biol 27:600-606
68. Masuda S, Murakami M, Mitsuishi M et al (2005) Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells. Biochem J 387:27-38 (Pubitemid 40524071)
69. Masuda S, Murakami M, Ishikawa Y et al (2005) Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues. Biochim Biophys Acta 1736:200-210 (Pubitemid 41423704)
70. Balestrieri B, Maekawa A, Xing W et al (2009) Group V secretory phospholipase A2 modulates phagosome maturation and regulates theinnate immune response against Candida albicans. J Immunol 182:4891-4898
71. Morioka Y, Saiga A, Yokota Y et al (2000) Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor. Arch Biochem Biophys 381:31-42
72. Mounier CM, Wendum D, Greenspan E et al (2008) Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2- III as a biomarker candidate. Br J Cancer 98:587-595 (Pubitemid 351214519)
73. Eerola LI, Surrel F, Nevalainen TJ et al (2006) Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels. Biochim Biophys Acta 1761:745-756 (Pubitemid 44108743)
74. Surrel F, Jemel I, Boilard E et al (2009) Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators. Mol Pharmacol 76:778-790
75. Hite RD, Seeds MC, Jacinto RB et al (1998) Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2. Am J Physiol 275:L740-L747
76. Pruzanski W, Lambeau L, Lazdunsky M et al (2005) Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. Biochim Biophys Acta 1736:38-50 (Pubitemid 41208258)
77. Karabina SA, Brocheriou I, Le Naour G et al (2006) Atherogenic properties of LDL particles modifi ed by human group X secreted phospholipase A2 on human endothelial cell function. FASEB J 20:2547-2549
78. Hallstrand TS, Chi EY, Singer AG et al (2007) Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med 176:1072-1078 (Pubitemid 350223752)
79. Henderson WR Jr, Chi EY, Bollinger JG et al (2007) Importance of group X-secreted phospholipase A2 in allergen-induced airway infl ammation and remodeling in a mouse asthma model. J Exp Med 204:865-877 (Pubitemid 46631615)
80. Giannattasio G, Fujioka D, Xing W et al (2010) Group V secretory phospholipase A2 reveals its role in house dust mite-induced allergic pulmonary infl ammation by regulation of dendritic cell function. J Immunol 185:4430-4438
81. Munoz NM, Meliton AY, Meliton LN et al (2009) Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic infl ammation caused by LPS in mice. Am J Physiol Lung Cell Mol Physiol 296:L879-L887
82. Sato H, Kato R, Isogai Y et al (2008) Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modifi cation, macrophage foam cell formation, and atherosclerosis. J Biol Chem 283: 33483-33497
83. Kimura-Matsumoto M, Ishikawa Y, Komiyama K et al (2008) Expression of secretory phospholipase A2s in human atherosclerosis development. Atherosclerosis 196:81-91
84. Masuda S, Murakami M, Matsumoto S et al (2004) Localization of various secretory phospholipase A2 enzymes in male reproductive organs. Biochim Biophys Acta 1686:61-76 (Pubitemid 39446879)
85. Escoffi er J, Jemel I, Tanemoto A et al (2010) Group X phospholipase A2 is released during sperm acrosome reaction and controls fertility outcome in mice. J Clin Invest 120:1415-1428
86. Gelb MH, Valentin E, Ghomashchi F et al (2000) Cloning and recombinant expression of a structurally novel human secreted phospholipase A2. J Biol Chem 275:39823-39826 (Pubitemid 32064600)
87. Huhtinen HT, Gronroos JO, Gronroos JM et al (2006) Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro. APMIS 114:127-130 (Pubitemid 43356923)
88. Rouault M, Bollinger JG, Lazdunski M et al (2003) Novel mammalian group XII secreted phospholipase A2 lacking enzymatic activity. Biochemistry 42:11494-11503 (Pubitemid 37205744)
89. Chabot S, Koumanov K, Lambeau G et al (2003) Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2. J Immunol 171:995-1000 (Pubitemid 36871415)
90. Saegusa J, Akakura N, Wu CY et al (2008) Pro-infl ammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner. J Biol Chem 283:26107-26115
91. 2+ infl ux in C2C12 myotubes. Toxicon 55:590-596
92. Boilard E, Bourgoin SG, Bernatchez C et al (2003) Identifi cation of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with infl ammatory group IIA phospholipase A2. Blood 102:2901-2909 (Pubitemid 37248863)
93. Smart BP, Oslund RC, Walsh LA et al (2006) The fi rst potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding. J Med Chem 49:2858-2860
94. Sato R, Yamaga S, Watanabe K et al (2010) Inhibition of secretory phospholipase A2 activity attenuates lipopolysaccharide-induced acute lung injury in a mouse model. Exp Lung Res 36:191-200
95. Fujioka D, Saito Y, Kobayashi T et al (2008) Reduction in myocardial ischemia/reperfusion injury in group X secretory phospholipase A2-defi cient mice. Circulation 117:2977-2985
96. Bowton DL, Dmitrienko AA, Israel E et al (2005) Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma. J Asthma 42:65-71 (Pubitemid 40365732)
97. Zeiher BG, Steingrub J, Laterre PF et al (2005) LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. Crit Care Med 33:1741-1748 (Pubitemid 41153699)
98. Ghosh M, Tucker DE, Burchett SA et al (2006) Properties of the Group IV phospholipase A2 family. Prog Lipid Res 45:487-510
99. Leslie CC (2004) Regulation of arachidonic acid availability for eicosanoid production. Biochem Cell Biol 82:1-17 (Pubitemid 38580870)
100. Leslie CC (2004) Regulation of the specifi c release of arachidonic acid by cytosolic phospholipase A2. Prostaglandins Leukot Essent Fatty Acids 70:373-376 (Pubitemid 38429270)
101. Jimenez JL, Smith GR, Contreras-Moreira B et al (2003) Functional recycling of C2 domains throughout evolution: a comparative study of synaptotagmin, protein kinase C and phospholipase C by sequence, structural and modelling approaches. J Mol Biol 333:621-639 (Pubitemid 37222410)
102. Hirabayashi T, Murayama T, Shimizu T (2004) Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol Pharm Bull 27:1168-1173 (Pubitemid 41701705)
103. Pickard RT, Chiou XG, Strifl er BA et al (1996) Identifi cation of essential residues for the catalytic function of 85-kDa cytosolic phospholipase A2. Probing the role of histidine, aspartic acid, cysteine, and arginine. J Biol Chem 271:19225-19231 (Pubitemid 26271587)
104. Dessen A (2000) Structure and mechanism of human cytosolic phospholipase A(2). Biochim Biophys Acta 1488:40-47
105. Ohto T, Uozumi N, Hirabayashi T et al (2005) Identifi cation of novel cytosolic phospholipase A(2)s, murine cPLA(2){delta}, {epsilon}, and {zeta}, which form a gene cluster with cPLA(2){beta}. J Biol Chem 280:24576-24583 (Pubitemid 40934545)
106. Ghosh M, Loper R, Ghomashchi F et al (2007) Function, activity, and membrane targeting of cytosolic phospholipase A(2)zeta in mouse lung fi broblasts. J Biol Chem 282:11676-11686 (Pubitemid 47100705)
107. Ghomashchi F, Naika GS, Bollinger JG et al (2010) Interfacial kinetic and binding properties of mammalian group IVB phospholipase A2 (cPLA2beta) and comparison with the other cPLA2 isoforms. J Biol Chem 285:36100-36111
108. Haq S, Kilter H, Michael A et al (2003) Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Nat Med 9:944-951 (Pubitemid 36889939)
109. Nagase T, Uozumi N, Ishii S et al (2002) A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fi brosis. Nat Med 8:480-484 (Pubitemid 34546750)
110. Miyaura C, Inada M, Matsumoto C et al (2003) An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with infl ammation. J Exp Med 197:1303-1310 (Pubitemid 36617777)
111. Hegen M, Sun L, Uozumi N et al (2003) Cytosolic phospholipase A2alpha-defi cient mice are resistant to collagen-induced arthritis. J Exp Med 197:1297-1302 (Pubitemid 36617776)
112. Bonventre J (2004) Cytosolic phospholipase A2alpha reigns supreme in arthritis and bone resorption. Trends Immunol 25:116-119 (Pubitemid 38249482)
113. Sanchez-Mejia RO, Newman JW, Toh S et al (2008) Phospholipase A2 reduction ameliorates cognitive defi cits in a mouse model of Alzheimer's disease. Nat Neurosci 11:1311-1318
114. Hartney JM, Coggins KG, Tilley SL et al (2006) Prostaglandin E2 protects lower airways against bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 290:L105-L113
115. Francois H, Athirakul K, Howell D et al (2005) Prostacyclin protects against elevated blood pressure and cardiac fi brosis. Cell Metab 2:201-207
116. Ilsley JN, Nakanishi M, Flynn C et al (2005) Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Res 65:2636-2643 (Pubitemid 40490062)
117. Meyer AM, Dwyer-Nield LD, Hurteau GJ et al (2004) Decreased lung tumorigenesis in mice genetically defi cient in cytosolic phospholipase A2. Carcinogenesis 25:1517-1524 (Pubitemid 39162717)
118. Downey P, Sapirstein A, O'Leary E et al (2001) Renal concentrating defect in mice lacking group IV cytosolic phospholipase A(2). Am J Physiol Renal Physiol 280:F607-F618
119. Wong DA, Kita Y, Uozumi N et al (2002) Discrete role for cytosolic phospholipase A(2) alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). J Exp Med 196:349-357 (Pubitemid 34875664)
120. Adler DH, Cogan JD, Phillips JA 3rd et al (2008) Inherited human cPLA(2alpha) defi - ciency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. J Clin Invest 118:2121-2131 (Pubitemid 351872331)
121. Reed KA, Tucker DE, Aloulou A et al (2011) Functional Characterization of Mutations in Inherited Human cPLA(2) Defi ciency. Biochemistry 50:1731-1738
122. Akiba S, Sato T (2004) Cellular function of calcium-independent phospholipase A2. Biol Pharm Bull 27:1174-1178
123. Balsinde J, Balboa MA (2005) Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells. Cell Signal 17:1052-1062 (Pubitemid 40933526)
124. 2+ -independent phospholipase A2. Biochim Biophys Acta 1392:320-332 (Pubitemid 28287334)
125. Jenkins CM, Yan W, Mancuso DJ et al (2006) Highly selective hydrolysis of fatty acyl-CoAs by calcium-independent phospholipase A2beta. Enzyme autoacylation and acyl-CoAmediated reversal of calmodulin inhibition of phospholipase A2 activity. J Biol Chem 281:15615-15624 (Pubitemid 43848447)
126. Sharma J, Turk J, McHowat J (2010) Endothelial cell prostaglandin I(2) and platelet- activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouse. Biochemistry 49:5473-5481
127. Yan W, Jenkins CM, Han X et al (2005) The highly selective production of 2-arachidonoyl lysophosphatidylcholine catalyzed by purifi ed calcium-independent phospholipase A2gamma: identifi cation of a novel enzymatic mediator for the generation of a key branch point intermediate in eicosanoid signaling. J Biol Chem 280:26669-26679 (Pubitemid 41040699)
128. Jenkins CM, Mancuso DJ, Yan W et al (2004) Identifi cation, cloning, expression, and purifi - cation of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 279:48968-48975 (Pubitemid 39625778)
129. Ghosh M, Loper R, Gelb MH et al (2006) Identifi cation of the expressed form of human cytosolic phospholipase A2beta (cPLA2beta): cPLA2beta3 is a novel variant localized to mitochondria and early endosomes. J Biol Chem 281:16615-16624
130. Wilensky RL, Macphee CH (2009) Lipoproteinassociated phospholipase A(2) and atherosclerosis. Curr Opin Lipidol 20:415-420
131. Packard CJ (2009) Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target. Curr Opin Cardiol 24:358-363
132. Arai H (2002) Platelet-activating factor acetylhydrolase. Prostaglandins Other Lipid Mediat 68-69:83-94 (Pubitemid 35247389)
133. Tjoelker LW, Wilder C, Eberhardt C et al (1995) Anti-infl ammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549-553
134. Samanta U, Bahnson BJ (2008) Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis. J Biol Chem 283:31617-31624
135. Stafforini DM, Tjoelker LW, McCormick SP et al (1999) Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem 274:7018-7024
136. Prescott SM, Zimmerman GA, Stafforini DM et al (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69:419-445
137. Tsimikas S, Tsironis LD, Tselepis AD (2007) New insights into the role of lipoprotein(a)- associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler Thromb Vasc Biol 27:2094-2099 (Pubitemid 350287235)
138. Macphee CH, Nelson JJ, Zalewski A (2005) Lipoprotein-associated phospholipase A2 as a target of therapy. Curr Opin Lipidol 16:442-446
139. Wilensky RL, Shi Y, Mohler ER 3rd et al (2008) Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 14:1059-1066
140. Serruys PW, Garcia-Garcia HM, Buszman P et al (2008) Effects of the direct lipoproteinassociated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 118:1172-1182
141. Kono N, Inoue T, Yoshida Y et al (2008) Protection against oxidative stress-induced hepatic injury by intracellular type II plateletactivating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo. J Biol Chem 283:1628-1636
142. Manya H, Aoki J, Watanabe M et al (1998) Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain. J Biol Chem 273:18567-18572 (Pubitemid 28334787)
143. Kitsiouli E, Nakos G, Lekka ME (2009) Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta 1792:941-953
144. 2+ -independent phospholipase A2 and properties of the expressed protein. J Biol Chem 272:2542-2550 (Pubitemid 27058548)
145. Chen JW, Dodia C, Feinstein SI et al (2000) 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem 275:28421-28427
146. Bridges JP, Ikegami M, Brilli LL et al (2010) LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice. J Clin Invest 120:1736-1748
147. Hiraoka M, Abe A, Lu Y et al (2006) Lysosomal phospholipase A2 and phospholipidosis. Mol Cell Biol 26:6139-6148 (Pubitemid 44204532)
148. Duncan RE, Sarkadi-Nagy E, Jaworski K et al (2008) Identifi cation and functional characterization of adipose-specifi c phospholipase A2 (AdPLA). J Biol Chem 283:25428-25436
149. Sers C, Emmenegger U, Husmann K et al (1997) Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors. J Cell Biol 136:935-944 (Pubitemid 27098748)
150. 2+ -independent cytosolic phospholipase A1/2 of the thiol hydrolase type. J Lipid Res 50:685-693
151. Sanchez-Alavez M, Klein I, Brownell SE et al (2007) Night eating and obesity in the EP3Rdefi cient mouse. Proc Natl Acad Sci USA 104:3009-3014 (Pubitemid 46327994)
152. Morgan CP, Insall R, Haynes L et al (2004) Identifi cation of phospholipase B from Dictyostelium discoideum reveals a new lipase family present in mammals, fl ies and nematodes, but not yeast. Biochem J 382:441-449 (Pubitemid 39243910)
153. Chen SC, Wright LC, Santangelo RT et al (1997) Identifi cation of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun 65:405-411 (Pubitemid 27053201)
154. Lu T, Ito M, Tchoua U et al (2001) Identifi cation of essential residues for catalysis of rat intestinal phospholipase B/lipase. Biochemistry 40:7133-7139 (Pubitemid 32554036)
155. Ghannoum MA (1998) Extracellular phospholipases as universal virulence factor in pathogenic fungi. Nippon Ishinkin Gakkai Zasshi 39:55-59
156. Schwarzer N, Nost R, Seybold J et al (1998) Two distinct phospholipases C of Listeria monocytogenes induce ceramide generation, nuclear factor-kappa B activation, and E-selectin expression in human endothelial cells. J Immunol 161:3010-3018 (Pubitemid 28425726)
157. Katan M (1998) Families of phosphoinositide- specifi c phospholipase C: structure and function. Biochim Biophys Acta 1436:5-17
158. Heinz DW, Essen LO, Williams RL (1998) Structural and mechanistic comparison of prokaryotic and eukaryotic phosphoinositidespecifi c phospholipases C. J Mol Biol 275:635-650 (Pubitemid 28064207)
159. Iwasaki Y, Nishikawa S, Tsuneda M et al (2004) Detection of phospholipase D on solid materials. Anal Biochem 329:157-159 (Pubitemid 38596916)
160. McDermott M, Wakelam MJ, Morris AJ (2004) Phospholipase D. Biochem Cell Biol 82:225-253 (Pubitemid 38580885)
161. Leiros I, Secundo F, Zambonelli C et al (2000) The fi rst crystal structure of a phospholipase D. Structure 8:655-667
162. Liscovitch M, Czarny M, Fiucci G et al (2000) Phospholipase D: molecular and cell biology of a novel gene family. Biochem J 345(Pt 3): 401-415 (Pubitemid 30099066)
163. McNamara PJ, Cuevas WA, Songer JG (1995) Toxic phospholipases D of Corynebacterium pseudotuberculosis. C. ulcerans and Arcanobacterium haemolyticum : cloning and sequence homology. Gene 156:113-118
164. Shimizu T, Ohto T, Kita Y (2006) Cytosolic phospholipase A2: biochemical properties and physiological roles. IUBMB Life 58:328-333 (Pubitemid 43880025)
165. Clausen K (2001) Enzymatic oil-degumming by a novel microbial phospholipase. Eur J Lipid Sci Technol 103:333-340
166. MacRitchie F (1977) Flour lipids and their effects in baking. J Sci Food Agric 28:53-58
167. Dutilh CE, Groger W (1981) Improvement of product attributes of mayonnaise by enzymic hydrolysis of egg yolk with phospholipase A2. J Sci Food Agric 32:451-458
168. Daimer K, Kulozik U (2008) Impact of a treatment with phospholipase A2 on the physicochemical properties of Hen Egg yolk. J Agric Food Chem 56:4172-4180 (Pubitemid 351967961)
169. Nebesny E, Rosicka J, Pierzgalski T (1998) Enzymatic hydrolysis of wheat starch into glucose. Starch - Stärke 50:337-341 (Pubitemid 128619892)
170. Lilbaek HM, Broe ML, Høier E et al (2006) Improving the yield of mozzarella cheese by phospholipase treatment of milk. J Dairy Sci 89:4114-4125 (Pubitemid 44682911)